Background: To describe patterns of antibiotic outpatient use in three European countries,
Introduction
Despite clear evidence that poorly targeted antibiotic use contributes to the major health problem of antimicrobial resistance, outpatient antibiotic prescribing in Europe remains high with a strong north-south gradient. [1] [2] [3] . Children are high consumers of antibiotics especially in the first years of life 4, 5 . Indeed, high rates of antibiotic prescribing in primary care, often for acute respiratory tract infections (RTIs) 6 , warrant close monitoring of childhood prescribing patterns. Yet, there have been few initiatives so far to assess quality of outpatient antibiotic prescribing in children 7 .
Quality indicators (QIs) have already been developed within the context of the European Surveillance of Antimicrobial Consumption (ESAC) project 8 based on outpatient use data.
However, these QIs are not directly applicable to pediatric antibiotic use because of the absence of age-specific pediatric defined daily dosages (DDDs) and age-related differences in the prevalence of infections and patterns of drug use between adults and children.
The Antibiotic Resistance and Prescribing in European children (ARPEC) project, aimed to improve antimicrobial prescribing in hospitals and in the community, by obtaining up-to-date, relevant data on variation in clinical management and antimicrobial resistance rates. Within this sub-project of ARPEC, we sought to describe patterns of antibiotic use in pediatric primary care in three European countries using, amongst others, two newly proposed pediatric-specific quality indicators.
and UK, general practitioners (GPs) are responsible for the primary care of children. The
Integrated Primary Care Information database (IPCI) from NL comprises electronic medical
records from more than 400 Dutch GPs since 1996 9, 10 . The Health Improvement Network (THIN) is a database of primary care medical records from UK, prospectively collecting data since September 2002 and containing retrospective data since the late 1980's 11 . In Italy, family pediatricians (FPs) are the gatekeepers of primary care for children less than 14 years of age. The
Pedianet database contains exclusively pediatric electronic medical records from 150 FPs in IT since 2000 12 . These databases contain the complete automated patient files, with detailed information on population, diagnoses and drug prescriptions. Their use has been proven valid for pharmacoepidemiologic research and data are representative of national pediatric populations with regard to gender and age distribution 11, 13 . Details about their structure have been described elsewhere 9, 10, 12, 14 .
Data from the different databases were pooled using a distributed network approach, in which dataholders maintain control over their original data and only anonymized and aggregated data are shared. This was done through generation of data into a common format followed by local data aggregation using custom-built software, Jerboa © 15 . The respective scientific and ethics committees of each database approved the conduct of the study.
Study period
As the start date for data collection differed between databases, the start of the study period was Penicillins with extended spectrum (J01CA) were the most frequently prescribed antibiotics particularly in the first years of life ( Figure 2 ). Overall, the most commonly prescribed antibiotic was amoxicillin: 9.2 % in NL, 19.7% in the UK and 18% in IT. Amoxicillin prescriptions peaked at the age of one to two years with a maximum of 30.5% in NL, 46% in the UK and 31.3% in IT.
Prescriptions for the class 'combinations of penicillins, incl. beta-lactamase inhibitors' (J01CR)
were frequent in NL and IT, while in the UK beta-lactamase sensitive penicillins were very frequently prescribed (J01CE).
In the macrolides class (J01FA), erythromycin was the main antibiotic prescribed in the UK, with a prevalence rate of 4.5%, peaking at one to two years of age (8.7%). In NL, clarithromycin (1.1%; maximal 3.3% at one to two years) and azithromycin (1.6%; maximal 3.4% at one to two years) were predominant. In IT, the prevalence rate of clarithromycin was 7.1% (maximal 11.1%
at three to four years) and that of azithromycin was 7.6% (maximal 12.8% at three to four years).
The prevalence of second and third generation cephalosporins (J01DC-DD) was high in IT, up to 4.1% and 6.8% at three to four years of age ( Figure 2 ), while in the UK and NL prevalence of cephalosporin use (J01D) was low (2.3%) and very rare (0.02%), respectively. In IT, thirdgeneration cephalosporins made up a large proportion of cephalosporin prescribing: cefixime (2.8% at three to four years), cefpodoxime (2% at three to four years) and ceftibuten (1.1% at one to two years).
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Ninety per cent of all antibiotic prescriptions (DU90%) in this population were covered by 9 drugs in NL and by 8 drugs in both UK and IT. In NL and UK, the number of drugs accounting for the DU90% increased with age, while this number was stable in Italy (table 1 a-c).
Quality Indicators
The B/N ratio was highest in IT for all ages and all calendar years. Across all three countries, the B/N ratio was highest in the youngest children: 5. The UK had the highest A/B ratio in all age categories (Table 3 ). In NL, the A/B ratio was also high however, the ratio decreased with increasing age; in adolescents between 14 and 18 years of age, users of broad-spectrum antibiotics were nearly twice those of amoxicillin. In IT, broadspectrum antibiotics were more commonly prescribed than amoxicillin in all age categories, though again the difference increased with increasing age. Over the years, the overall number of users of amoxicillin compared to that of broad-spectrum antibiotics increased in NL whereas it decreased in the UK and in IT.
Discussion
In this cohort study we describe patterns of primary care prescribing of antibiotic agents in children in three European countries. More than 2 million children aged 0-<18 years were
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included, contributing over 12 million PYs of follow up through a period of 10 to 16 years.
Based on this large cohort, we were able to demonstrate the application of two new QIs of pediatric community-based antibiotic prescribing, the AI and the A/B ratio.
Expectedly, we found that the antibiotic prescribing prevalence rates were lowest in NL (18% per year), 36% per year in the UK and highest in IT (52% per year) 4, 5, 20 . Antibiotic prescribing tended to slightly decrease over time in all countries, though this decrease was not statistically significant in NL. Although there was considerable variability in the type of antibiotics that were most commonly prescribed, amoxicillin was the most commonly prescribed antibiotic in all three countries. However, the number of antibiotics making up the DU90% was similar across the three countries, demonstrating the limited repertoire of antibiotics making up the bulk of community-based antibiotic prescribing for children. These findings are in line with recent European data also placing IT and NL at the two extremes of antibiotic use and Germany, UK
and Denmark between those extremes, at decreasing prevalence rates 21, 22 .
Broad-spectrum antibiotic prescribing increased in all countries in the studied period and was highest in IT. The B/N ratio was highest in the youngest children. The overall ratios for children were somewhat lower than the ESAC findings for adults in 2004 for the UK (0.3 vs. 0.56) and NL (3.2 vs. 5.12), and higher in Italy (74.7 vs. 50.9) 8 . For pediatric patients, this ratio is highly variable and hard to interpret especially as certain drugs, such as penicillin V (phenoxymethylpenicillin), are not available in specific countries.
We developed and assessed two new simple QIs to evaluate the quality of community-based antibiotic prescribing, the AI and the A/B ratio, which revealed important differences in antibiotics prescribed, both between age groups and countries. The AI was highest in the UK and NL (50%) and lowest in IT (30%), which is compatible with the much higher annual exposure of Copyright © 2016 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
Italian children to macrolides, to penicillins with beta-lactamase inhibitors and to 3 rd /4 th generation cephalosporins. The A/B ratio provided further detail. This ratio was highest for the UK (A/B ratio of 6, that is 6 amoxicillin users observed for one broad-spectrum antibiotic user in a given calendar year) followed by NL (A/B ratio of 2). Together with the AI, this can be interpreted as greater prescribing preference for narrower-spectrum antibiotics, such as betalactamase susceptible penicillins, as alternatives to amoxicillin in the UK compared to NL. Thus, although overall prescribing in NL is lower than in the UK, children receiving antibiotics are more likely to be prescribed broader-spectrum agents than in the UK. In IT, the A/B ratio is reversed (<1), indicating that prescriptions of broad-spectrum agents are altogether more common than amoxicillin prescriptions.
The selection of amoxicillin as the reference standard to evaluate the quality of antibiotic prescribing may seem somewhat arbitrary. However, upper and lower respiratory tract infections remain by far the most common indications for childhood antibiotic prescribing in community practice 5, 23 . Many guidelines recommend amoxicillin as the first-line choice for suspected bacterial respiratory tract infections, including pneumonia and otitis media. [24] [25] [26] [27] Several patterns in our data support the role of amoxicillin in assessing antibiotic prescribing quality in the childhood population. In all three countries, seasonal variation with peak prescribing in winter, in line with the seasonal trend of the incidence of acute respiratory infections, was observed (data not shown) 28 . The high AI in NL and the UK as well as the substantial contribution of macrolides and penicillins combined with beta-lactamase inhibitors in IT support the interpretation that a large proportion of childhood community-based antibiotic prescribing targets acute respiratory infections. The AI was highest in the youngest children, who are also most frequently treated with antibiotics for respiratory infections 29, 30 .
Equally a drop in the A/B ratio
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13 from infancy to preschool age may be partially explained by the increasing use of macrolides with increasing age due to the unresolved questions about the need to cover for atypical pathogens in older children 31 .
As many prescriptions are likely to be issued to children with viral respiratory infections, efforts are needed to reduce prescribing in this setting 32 . Amoxicillin consumption could reflect the part of antibiotic use in children that has the greatest potential for reduction 5 . In the 15 years covered by this study considerable effort has been put in reducing inappropriate prescriptions of antibiotics in Europe 7, 33, 34 . Despite these efforts, the overall change in prevalence rates observed in this study over time was very small. Yet, major interventions can effectively reduce inappropriate antibiotic prescribing 35 . In France, national campaigns focusing on inappropriate antibiotic prescribing for respiratory tract infections of viral origin in children aged 0 to 6 years reported a 35.8% reduction in antibiotic prescriptions 36 .
However, beyond aiming to achieve an overall reduction in antibiotic prescribing, it may also be necessary to improve the quality of antibiotic selection. In the UK, narrow-spectrum penicillins were the second most commonly prescribed antibiotic class after amoxicillin whereas in NL amoxicillin with enzyme inhibitor and macrolides were preferred. In IT, third-generation oral cephalosporins and macrolides were very commonly used together with amoxicillin with or without enzyme inhibitor, a pattern that has already been described in previous drug utilization studies 37 . Likewise, use of broad-spectrum antibiotics, oral cephalosporins and macrolides, in
Germany has been noted as comparable to that of IT whereas antibiotic prescriptions in Denmark concern almost exclusively narrow-spectrum agents 21, 22 . Differences in prescribed antibiotics among the countries can partly be explained by availability of antibiotics and differences in guidelines. For example, penicillin V is not available in Italy whereas it is widely used in the In the absence of pediatric DDDs, we reported total and class specific consumption as prevalence rates, which may also be more explicit for primary care physicians. We also derived two simple new QIs which provide useful information and trends over time, but need to be age-specific since both antibiotic prescribing and the prevalence of infectious diseases are age-dependent. A key limitation of the current study is that we could not stratify our results by clinical indications as the latter were not collected. In future studies, stratification by indication may give more insight in the quantitative and qualitative differences of antibiotic prescribing between countries. It can also provide valuable epidemiological information by drawing inferences on the proportion of children treated for a specific indication. This information is crucial to assess whether antibiotic prescribing policies can be further optimized.
In conclusion, assessment of antibiotic consumption in these three countries identified distinct patterns of use. In the UK, prevalence of antibiotic prescribing remains moderately high with only a slight reduction in global and amoxicillin use over time; however prescribing of broadspectrum antibiotics is low. Conversely in NL consumption of antibiotics is low and remains stable, but broad-spectrum antibiotic prescribing is progressively increasing compared to narrowspectrum classes. Finally, antibiotic prescription patterns in IT are dominated by broad-spectrum agents. These patterns were most easily visualised and evaluated using two new simple quality Prevalence of prescribed antibiotic classes by age and country 
